Trial | Year | N | Mean Follow-up (months) | Mean age (years) | Per cent male | Mean EF (%) | Per cent IHD | Per cent DM | ||
---|---|---|---|---|---|---|---|---|---|---|
1 | Calkins et al23 | SCV vs cephalic approach | 2001 | 71 | 18 | 65 | 61 | 42 | NA | NA |
2 | Deisenhofer et al24 | Dual vs single chamber | 2001 | 92 | 8 | 61 | 90 | NA | 67 | NA |
3 | Kron et al8 | AVID | 2001 | 539 | 27 | 65 | 79 | 32 | 81 | 26 |
4 | Bänsch et al25 | CAT | 2002 | 50 | 66 | 52 | 86 | 24 | 0 | NA |
5 | Moss et al26 | MADIT | 2002 | 742 | 20 | 64 | 84 | 23 | 100 | 33 |
6 | Vollman et al27 | 6944 vs 6942 | 2003 | 542 | 11 | 65 | 83 | 34 | 72 | NA |
7 | Bänsch et al28 | 1+1 | 2004 | 102 | 12 | NA | NA | 38 | 82 | NA |
8 | Bokhari et al29 | CIDS subset | 2004 | 60 | 67 | 64 | 83 | 34 | 80 | 12 |
9 | Hohnloser et al30 | DINAMIT | 2004 | 310 | 30 | 62 | 81 | 28 | 100 | 31 |
10 | Kadish et al11 | DEFINITE | 2004 | 229 | 29 | 58 | 72 | 21 | 0 | 23 |
11 | Bänsch et al31 | Quick-ICD | 2007 | 190 | 12 | 63 | 86 | 41 | 64 | NA |
12 | Reddy et al32 | SMASH-VT | 2007 | 128 | 22 | 67 | 87 | 32 | 100 | 44 |
13 | Almendral et al10 | DATAS | 2008 | 334 | 15 | 64 | 84 | 36 | 85 | 24 |
14 | Russo et al33 | INTRINSIC RV | 2009 | 1530 | 11 | 65 | 81 | NA | 58 | 27 |
15 | Steinbeck et al7 | IRIS | 2009 | 415 | 37 | 63 | 83 | 35 | 77 | 37 |
16 | Kuck et al34 | VTACH | 2010 | 107 | 23 | 66 | 93 | 34 | 100 | NA |
17 | Varma et al35 | TRUST | 2010 | 1339 | 11 | 64 | 72 | 29 | 67 | NA |
18 | Cheng et al36 | Warfarin | 2011 | 16 | 1 | 71 | 79 | 37 | 49 | 23 |
Summary estimate | 6796 | 17.9 | 64 | 80 | 30.5 | 74.0 | 29.1 |
DM, diabetes mellitus; IHD, ischaemic heart disease; NA, not available.